Back to Search
Start Over
Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables
- Source :
- Blood; December 2016, Vol. 128 Issue: 22 p3802-3802, 1p
- Publication Year :
- 2016
-
Abstract
- Cid: Baxalta Innovations GmbH, now part of Shire: Other: Investigator Clinical Studies.
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 128
- Issue :
- 22
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs53027660
- Full Text :
- https://doi.org/10.1182/blood.V128.22.3802.3802